Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Brief: Zealand Pharma Gets Positive CHMP Opinion For Zeydovio For Treatment Of Short Bowel Syndrome

    Picture of Zealand Pharma A/S logoZealand Pharma A/S
    18/09/2026 11:12
    BRIEF-Zealand Pharma Gets Positive CHMP Opinion For Zeydovio For Treatment Of Short Bowel Syndrome
    Sept 18 (Reuters) - Zealand Pharma A/S ZELA.CO:
    • ZEALAND PHARMA RECEIVES POSITIVE CHMP OPINION FOR ZEYDOVIO™ (GLEPAGLUTIDE) FOR THE TREATMENT OF SHORT BOWEL SYNDROME
    • POSITIVE CHMP OPINION MARKS FIRST MAJOR ADVANCEMENT IN SHORT BOWEL SYNDROME TREATMENT IN EUROPE IN MORE THAN A DECADE
    Source text: ID:nGNE3lvGCK
    Further company coverage: ZELA.CO

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Zealand Pharma A/S

    See all news